Dr Sheraz Gul is currently Vice President and Head of Biology at European ScreeningPort, Hamburg, Germany. He is responsible for the management of assay development and Medium and High Throughput Screening activities for academic and commercial partners across Europe. He has twelve years research experience in both academia (University of London) and industry (GlaxoSmithKline Pharmaceuticals). This has ranged from the detailed study of catalysis by biological catalysts (enzymes and catalytic antibodies) to the design and development of assays for High Throughput Screening. Whilst working at GSK he developed numerous biochemical and cellular assays for High Throughput Screening and evaluated… compounds up to Candidate Selection. He is co-author of numerous papers, book chapters, and the Enzyme Assays: Essential Data Handbook. In addition, he is on the editorial board of the European Pharmaceutical Review for which he writes regular articles in the lab automation section.